Leah H. Biller

Oncology

300 Boylston St
Chestnut Hill, MA 02467

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Genomic characterization of therapy-associated polyposis reveals an alkylating mutational signature from prior treatment.

Genomic characterization of therapy-associated polyposis reveals an alkylating mutational signature from prior treatment.

Journal: The Journal of clinical investigation

Published: August 04, 2026

Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era.

Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era.

Journal: JCO precision oncology

Published: October 11, 2025

Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.

Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.

Journal: JCO precision oncology

Published: September 02, 2025

A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.

A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 24, 2025

Erratum: Comparison of PREMM5 and PREMMplus Risk Assessment Models to Identify Lynch Syndrome.

Erratum: Comparison of PREMM5 and PREMMplus Risk Assessment Models to Identify Lynch Syndrome.

Journal: JCO precision oncology

Published: February 24, 2025

Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab.

Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab.

Journal: medRxiv : the preprint server for health sciences

Published: October 17, 2024

Experience and Needs of Patients With Young-Onset Colorectal Cancer and Their Caregivers: A Qualitative Study.

Experience and Needs of Patients With Young-Onset Colorectal Cancer and Their Caregivers: A Qualitative Study.

Journal: JCO oncology practice

Published: June 28, 2024

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.

Journal: Cancer immunology research

Published: February 07, 2024

Cancer Diagnoses After Recent Weight Loss.

Cancer Diagnoses After Recent Weight Loss.

Journal: JAMA

Published: January 23, 2024

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.

Journal: Journal for immunotherapy of cancer

Published: January 09, 2024

A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.

A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 17, 2023

G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans.

G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans.

Journal: Journal for immunotherapy of cancer

Published: June 04, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026